Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.

Background: Peptide receptor radionuclide therapy (PRRT) is an effective method for treating neuroendocrine tumors (NETs). It is limited, however, in the prediction of individual tumor response and the precise and early identification of changes in tumor size. Currently, response prediction is based...

Full description

Bibliographic Details

Published in:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 43; no. 5; pp. 839 - 852
Main Authors:	Bodei, L., Kidd, M., Modlin, I., Severi, S., Drozdov, I., Nicolini, S., Kwekkeboom, D., Krenning, E., Baum, R., Paganelli, G.
Format:	Journal Article
Published:	Springer Nature May2016
Online Access:	View this record in EBSCOhost